Novel mutations of CDKN1C in Japanese patients with Beckwith-Wiedemann syndrome
Novel mutations of CDKN1C in Japanese patients with Beckwith-Wiedemann syndrome
复制标题
DOI:
10.1007/s13258-013-0079-3
复制
发表时间:
2013-04-01
期刊:
影响因子:
2.1
通讯作者:
Soejima, Hidenobu
中科院分区:
文献类型:
--
作者:
Yatsuki, Hitomi;Higashimoto, Ken;Soejima, Hidenobu
Beckwith-Wiedemann syndrome (BWS) is an imprinting-related human disease that is characterized by macrosomia, macroglossia, abdominal wall defects, and variable minor features. BWS is caused by several genetic/epigenetic alterations, such as loss of methylation at KvDMR1, gain of methylation at H19-DMR, paternal uniparental disomy of chromosome 11, CDKN1C mutations, and structural abnormalities of chromosome 11. CDKN1C is an imprinted gene with maternal preferential expression, encoding for a cyclin-dependent kinase (CDK) inhibitor. Mutations in CDKN1C are found in 40 % of familial BWS cases with dominant maternal transmission and in similar to 5 % of sporadic cases. In this study, we searched for CDKN1C mutations in 37 BWS cases that had no evidence for other alterations. We found five mutations-four novel and one known-from a total of six patients. Four were maternally inherited and one was a de novo mutation. Two frame-shift mutations and one nonsense mutation abolished the QT domain, containing a PCNA-binding domain and a nuclear localization signal. Two missense mutations occurred in the CDK inhibitory domain, diminishing its inhibitory function. The above-mentioned mutations were predicted by in silico analysis to lead to loss of function; therefore, we strongly suspect that such anomalies are causative in the etiology of BWS.